z-logo
open-access-imgOpen Access
Serum Angiotensin-Converting Enzyme as a Marker of Dialyzer Membrane Biocompatibility?
Author(s) -
Bernhard K. Krämer,
Thomas Ulshöfer,
K.M. Ress,
Gerhard A. Müller,
T. Risler
Publication year - 1989
Publication title -
˜the œnephron journals/nephron journals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.951
H-Index - 72
eISSN - 2235-3186
pISSN - 1660-8151
DOI - 10.1159/000185731
Subject(s) - medicine , biocompatibility , enzyme , renin–angiotensin system , angiotensin converting enzyme , membrane , angiotensin ii , nephrology , urology , endocrinology , pathology , biochemistry , blood pressure , biology , chemistry , organic chemistry
Dr. B.K. Krämer, Medizinische Universitätsklinik, Otfried-Müller-Strasse 10, D-7400 Tübingen (FRG) Sir, We have read with interest the recent letters of Maher et al. [1] and Docci et al. [2]. Both authors suggest that serum angiotensin-converting enzyme is not a useful marker of dialysis membrane biocompatibility, in contrast to earlier findings of Nielsen et al. [3]. 16 patients on maintenance haemodialysis for 2–186 months were studied during haemodialysis with cupro-phane and non-cuprophane membranes [4]. Serum angiotensin-converting enzyme decreased slightly during haemodialysis, independent of the dialyzer membrane used. In addition, serum angiotensin-converting enzyme levels were nearly identical during use of a cuprophane and a non-cuprophane dialyzer membrane (82.3 ± 3.9 U/min/1 vs. 82.6 ± 3.3 U/min/1; range of normal values 18–40 U/min/1, corrected for haemoconcentration) [4]. Serum angiotensin-converting enzyme levels were compared with duration of maintenance haemodialysis in 23 patients (duration of maintenance haemodialysis from 2 to 216 months; age 34–78 years; etiology of renal failure: glomerulonephritis (n = 6), diabetic nephropathy (n = 5), polycystic kidney disease (n = 3), pyelonephritis (n = 2), hypertension (n = l), multiple myeloma (n = l), renal artery stenosis (n = 1), unknown (n = 4)). No significant correlation between serum angiotensin-converting enzyme and duration of maintenance haemodialysis was demonstrable (fig. 1). Our results imply that serum angiotensin-converting enzyme cannot be used as an indicator of dialyzer membrane biocompatibility and are in accordance with the results of other investigators [1, 2, 5–7]. Elevated serum angiotensin-converting enzyme levels in haemodialysis patients have also been demonstrated by several investigators [5, 6, 8–10], but have not been confirmed by others [1–3, 7, 11]. In contrast to our results, most authors were not able to demonstrate a change in serum angiotensin-

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom